Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
A rollercoaster end to last week for Novo Nordisk, with fourth-quarter results and a 2026 guide that were not well received by the market, followed by news that Hims & Hers planned to sell a non-FDA-approved compounded copy of Novos newly launched Wegovy pill
CBS News found that exposures reported to America's Poison Centers surged to an average of 95 cases per month in early 2026, a 265% increase from late 2025
Tirzepatide is a dual agonist that co-activates the GIP receptor (glucose-dependent insulinotropic polypeptide receptor) alongside GLP-1R
(PubMed) Hess SY
US$ 25.76
US$ 23.65
US$ 21.16
US$ 29.31
US$ 20.90
